← Back to patent-cliff list

CAS 143900-44-1

(S)-tert-butyl 3-hydroxypiperidine-1-carboxylate(3S)-1-(tert-Butoxycarbonyl)-3-hydroxypiperidinetert-butyl (S)-3-hydroxypiperidine-1-carboxylate

Codes: IBRT-006, (VI)461018-5-a, (I)461018-6-a, (V)461018-8-a, (IIIa)461018-11-a, (I)461018-12-a, (I)461018-20-a, (I)461018-21-a, (X)461018-26-a, (I)461018-32-a, HYML-122-005

Application context (from source-drug indications)

Waldenström macroglobulinaemiaIbrutinibChronic lymphocytic leukaemiaIbrutinibMantle cell lymphomaIbrutinibGraft-versus-host diseaseIbrutinibAcute myeloid leukaemiaHYML-122

Source drugs (routes using this intermediate)

DrugTierExpiry
IbrutinibTier A — Act now2027
HYML-122Tier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Sitetert-butyl (S)-3-hydroxypiperidine -1-carboxylate
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.